You just read:

Samumed Presents At The Annual Meeting Of The American Academy Of Dermatology (AAD) Safety And Efficacy Results From Its Phase 2 Androgenetic Alopecia (AGA) Trial

News provided by

Samumed, LLC

Mar 07, 2016, 09:20 ET